Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth muscle cells with or without alpha lipoic acid

Proteomics
Won Gu JangIn-Kyu Lee

Abstract

Vascular smooth muscle cells (VSMCs) play an important role in the development and progression of atherosclerosis. Tumor necrosis factor alpha (TNFalpha), a cytokine secreted by VSMCs and macrophages in atherosclerotic lesions, regulates a variety of cellular functions of inflammatory cells and VSMCs by promoting cell growth and motility, which are critical for the initiation and progression of vascularlesions. Alpha lipoic acid (ALA), a well known antioxidant, acts as a pyruvate dehydrogenase cofactor in mitochondrial metabolism. Recently, we reported that ALA has many beneficial effects on vascular cells in atherosclerosis. The aim of the current study was to examine VSMCs, treated for 24 hours with TNFalpha (10 ng/mL) in the presence or absence of ALA (2 mM), for differential protein and genes expression using two-dimensional gel electrophoresis (2-DE) and DNA microarray analysis, respectively. Using 2-DE, we identified proteins whose expression changed by at least 2.5-fold after TNFalpha stimulation. Proteins up-regulated by TNFalpha that were subsequently down-regulated in the presence of ALA were identified by matrix-assisted laser desorption/ionization-time of flight mass spectrometry as plasminogen activator inhibitor-2...Continue Reading

References

Jan 1, 1992·Free Radical Research Communications·R SchreckP A Baeuerle
Aug 17, 1990·European Journal of Biochemistry·U CarlbergO Nygård
Jun 29, 1995·Biochemical Pharmacology·P OuS P Wolff
Jul 1, 1995·Physiological Reviews·G K Owens
Aug 1, 1995·Free Radical Biology & Medicine·L PackerH J Tritschler
Mar 8, 1995·Biochemical and Biophysical Research Communications·S MatsugoL Packer
Apr 15, 1993·European Journal of Biochemistry·N T RedpathC G Proud
Mar 1, 1996·Toxicology and Applied Pharmacology·N L AndersonP Eacho
Dec 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·S JovingeJ Nilsson
Feb 7, 1998·Science·A Hall
Jun 9, 2001·Biochemical and Biophysical Research Communications·Z ZhuJ T Dalton
Nov 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·W J Zhang, B Frei
Jan 5, 2002·Experimental Gerontology·Heather A Lee, David A Hughes
Feb 10, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Ashwani Khanna
Feb 27, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·D ZieglerP A Low

❮ Previous
Next ❯

Citations

Mar 16, 2005·Current Opinion in Lipidology·Tiina T Tuomisto, Seppo Ylä-Herttuala
Apr 3, 2007·Molecular Diagnosis & Therapy·Melanie Y White, Jennifer E Van Eyk
Sep 24, 2005·The FEBS Journal·Robert L Medcalf, Stan J Stasinopoulos
Feb 1, 2008·Proteomics. Clinical Applications·Franck BrouillardMario Ollero
Jun 26, 2014·Proteomics. Clinical Applications·Lauren E Smith, Melanie Y White
Jun 23, 2005·Drug Discovery Today·Koen J Dechering
May 1, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aiping ZhaoTerez Shea-Donohue
Oct 21, 2016·Journal of Proteome Research·Rodolfo CiuffaRuedi Aebersold

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.